The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
Services
Subscribe
Advertise
Rights & permissions
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Contact us
Author centre
Dobrin Vassilev
Showing 1-7 of 7 articles
Regular drug-eluting stents versus dedicated bifurcation drug-eluting BiOSS stents for coronary bifurcation treatment: four-year results of the randomised POLBOS I and POLBOS II clinical trials
Gil R,
Bil J,
Kern A,
Ingio Garcia L,
Formuszewicz R,
Dobrzycki S,
Vassilev D,
Segiet A
March 20, 2020 | 10.4244/EIJ-D-18-00172
Intracoronary electrocardiogram to guide percutaneous interventions in coronary bifurcations – a proof of concept: the FIESTA (Ffr vs. IcEcgSTA) study
Vassilev D,
Dosev L,
Collet C,
Karamfiloff K,
Stoikova J,
Pancheva R,
Shumkova M,
Zlatancheva G,
Naunov V,
Rigatelli G,
Kassab G,
Gil R,
Serruys P
August 3, 2018 | 10.4244/EIJ-D-17-00189
Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM® stent: the randomised, multicentre, open-label, controlled POLBOS II trial
Gil R,
Bil J,
Grundeken M.J,
Kern A,
Iñigo Garcia L,
Vassilev D,
Pawłowski T,
Formuszewicz R,
Dobrzycki S,
Wykrzykowska JJ,
Serruys P
December 9, 2016 | 10.4244/EIJY15M11_11
Long-term effectiveness and safety of the sirolimus-eluting BiOSS LIM® dedicated bifurcation stent in the treatment of distal left main stenosis: an international registry
Gil R,
Bil J,
Grundeken M.J,
Iñigo Garcia L,
Vassilev D,
Kern A,
Pawłowski T,
Wykrzykowska JJ,
Serruys P
November 20, 2016 | 10.4244/EIJY15M10_05
The BiOSS stent
Gil R,
Bil J,
Vassilev D
May 19, 2015 | 10.4244/EIJV11SVA37
Dedicated paclitaxel-eluting bifurcation stent BiOSS® (bifurcation optimisation stent system): 12-month results from a prospective registry of consecutive all-comers population
Gil R,
Vassilev D,
Michalek A,
Kern A,
Formuszewicz R,
Dobrzycki S,
Wójcik J,
Lesiak M,
Kardaszewicz P,
Lekston A
July 27, 2012 | 10.4244/EIJV8I3A50
Bifurcation Optimisation Stent System (BiOSS Lim) with sirolimus elution: results from porcine coronary artery model
Vassilev D,
Gil R,
Milewski K
September 30, 2011 | 10.4244/EIJV7I5A98
1
Latest news
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
PCR London Valves 2023
November 16, 2023
NEW ISSUE
PCR London Valves special edition. State-of-the-art on TMVI; the timing of TMVI; direct wire pacing for TMVR; predicting patient-prosthesis mismatch following TAVI and more
November 17, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023
AHEAD OF PRINT
Cardiac damage classification in each AS subtype
FREE ARTICLE - Masaaki Nakase et al
November 6, 2023
AHEAD OF PRINT
CAPTIS embolic protection during TAVR
FREE ARTICLE - Haim D. Danenberg et al
November 2, 2023